LEVROXA
Manufacturer Details
SUN PHARMA
Compositions:
Levetiracetetam 250mg/500mg/750mg tablets,
|
Strength
|
Rate
|
Packing Style
|
|
250mg
|
57.00
|
10s tablets
|
|
500mg
|
115.00
|
10s tablets
|
|
750mg
|
177.02
|
10s tablets
|
List of Related Indications:
- Partial seizures in epilepsy
List Of Drugs:
- Levetiracetetam- Anticonvulsants-(Feb 2006)
Indication Type Description:
Drug Interaction:
St.Johns Wort
Indication:
LIST OF DRUGS DURING 2006
Sr.No- 21
Name of the Drug- Levetiracetam Oral solution (100mg/ml) Pharmacological Classification- Anti-epileptic
Date of Approval- 24-02-2006
Approved by U.S.FDA on 30-12-2006 (Ref- FDA approved List- 2006)
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
1.Levetiracetam oral solution 24-02-2006
100mg/ml
Anti-epileptic
2.Levetiracetam SR tablet 02-05-2009
500mg/750mg/1000mg
Same as approved
3.Levetricetatam tablet 09-10-2007
( Addl.Indn.)
i.As monotherapy in patial onset seizures with or without secondary
generalisation in patients with 16 years of age with newly diagnosed
epilepsy
ii. As adjunctive therapy in monoclonic seizures in adults and adolesecent
from 12 years of age with juvenile mycolinic epilepsy in primary generalised
tonic clonic seizures in adults and adolosecents from 12 years of age with
idiopathic generalised epilepsy
Seizures
Adverse Reaction:
Accidental injury, headache, anorexia, G.I upset, Asthenia, Ataxia Abnormal gait, somnolence, amnesia, convulsions. Dizziness, Anxiety, Anger, Apathy, depression, mood altered, negativism, terafulness, emotional lability Hostility, Aggresion, Irritability, psychosis, insomnia, Vertigo, tremor, confusion, nervousness, diplopia, Skin rash, infection Myclonic seizures. Hepatic failure, Suicidal ideation or behaviour
Contra-Indications:
Lactation
Special Precaution-
Renal or hepatic impairment, Withdraw slowly Elderly, Pregnancy, labour St.Johns Wort
Dosages/ Overdosage Etc:
Date Of Approval 2006
Indication
Partial seizures
Dosage-
Monotherapy- Initially 250mg twice daily, increasing to 500mg twice daily after 2 weeks then by 250mg twice daily every 2 weeks, according to response Maximum 1500mg twice daily If required increase in increments of 500mg twice daily every 2-4 weeks, Maximum 1500mg twice daily
Pregnancy and lactation:
Contra-indicated during pregnancy and lactation
